Back to Search Start Over

Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer.

Authors :
UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie
UCL - (SLuc) Service de gastro-entérologie
Geva, Ravit
Vecchione, Loredana
Tejpar, Sabine
Piessevaux, Hubert
Van Cutsem, Eric
Prenen, Hans
UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie
UCL - (SLuc) Service de gastro-entérologie
Geva, Ravit
Vecchione, Loredana
Tejpar, Sabine
Piessevaux, Hubert
Van Cutsem, Eric
Prenen, Hans
Source :
OncoTargets and Therapy, Vol. 6, p. 53-58 (2013)
Publication Year :
2013

Abstract

Taking into account the retrospective nature of the study which can influence the selection of patients, bevacizumab given in advanced lines after failure of conventional chemotherapy and antiepidermal growth factor receptor agents can result in high disease control rates in patients with mCRC.

Details

Database :
OAIster
Journal :
OncoTargets and Therapy, Vol. 6, p. 53-58 (2013)
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1130496319
Document Type :
Electronic Resource